MANFRINI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.200
EU - Europa 1.230
AS - Asia 421
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 3.858
Nazione #
US - Stati Uniti d'America 2.200
IT - Italia 415
PL - Polonia 331
CN - Cina 227
DE - Germania 186
UA - Ucraina 120
TR - Turchia 82
SG - Singapore 65
GB - Regno Unito 58
SE - Svezia 33
FI - Finlandia 30
RU - Federazione Russa 24
ID - Indonesia 20
FR - Francia 13
VN - Vietnam 13
CZ - Repubblica Ceca 8
IN - India 7
ES - Italia 4
IR - Iran 3
AL - Albania 2
CO - Colombia 2
EU - Europa 2
HK - Hong Kong 2
MK - Macedonia 2
NL - Olanda 2
AU - Australia 1
BD - Bangladesh 1
GR - Grecia 1
LB - Libano 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 3.858
Città #
Warsaw 331
Fairfield 262
Woodbridge 204
Houston 194
Chandler 181
Jacksonville 151
Ashburn 149
Wilmington 112
Cambridge 100
Seattle 100
Ann Arbor 94
Ferrara 68
New York 64
Izmir 56
Shanghai 47
Nanjing 46
Princeton 46
Milan 38
Beijing 37
Boardman 36
Singapore 34
Addison 33
San Diego 28
Bremen 26
Nanchang 21
Jakarta 19
Redwood City 17
Bologna 16
Dong Ket 13
Rome 13
Hebei 12
Shenyang 11
Dearborn 10
Auburn Hills 9
Brno 8
Kunming 8
Tianjin 8
Treviso 8
Mountain View 7
London 6
Serra 6
Torino 6
Changsha 5
Istanbul 5
Jiaxing 5
Cagliari 4
Des Moines 4
Falls Church 4
Ferrara di Monte Baldo 4
Guangzhou 4
Hefei 4
Leawood 4
Napoli 4
Norwalk 4
Washington 4
Zhengzhou 4
Brescia 3
Genova 3
Hangzhou 3
Hanover 3
Helsinki 3
Imola 3
Los Angeles 3
Modena 3
Padova 3
Palermo 3
Parma 3
Rimini 3
San Mateo 3
Tappahannock 3
Augusta 2
Boscotrecase 2
Hong Kong 2
Hounslow 2
Hyderabad 2
Indiana 2
Jinan 2
Latina 2
Livorno 2
Marigliano 2
Marzabotto 2
Orange 2
Paris 2
Pune 2
Redmond 2
San Jose 2
Sciacca 2
Siano 2
Varese 2
Abano Terme 1
Alghero 1
Amsterdam 1
Ancona 1
Andover 1
Arcevia 1
Ardabil 1
Auckland 1
Bari 1
Bogotá 1
Bryanston 1
Totale 2.785
Nome #
Citocompatibilità di biomateriali: osteoblasti umani ingegnerizzati fluorescenti 331
Serum IgG antibodies from pregnant women reacting to mimotopes of simian virus 40 large T antigen, the viral oncoprotein 219
HUMAN MESENCHYMAL STEM CELLS AS A MODEL OF STUDY FOR NEW BIOMATERIALS IN BONE TISSUE REGENERATION 171
Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects 156
Innovative Biomaterials for Bone Regrowth 141
Specific IgG antibodies react to mimotopes of BK Polyomavirus, a small DNA tumor virus, in healthy adult sera 133
null 132
MICRORNAS DYSREGULATION IN HUMAN MALIGNANT PLEURAL MESOTHELIOMA 124
Mesenchymal stem cells from patients to assay bone graft substitutes 115
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 105
High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma 103
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 99
Human adipose stem cells induced to osteogenic differentiation by an innovative collagen/hydroxylapatite hybrid scaffold 92
Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors 91
A3 RECEPTORS ARE OVEREXPRESSED IN PLEURA FROM PATIENTS WITH MESOTHELIOMA AND REDUCE CELL GROWTH VIA AKT/NUCLEAR FACTOR-KB PATHWAY 90
IN-LINE FILTERS ADSORPTION ASSAY OF THE ANTI-CANCER DRUG TAXOL 87
Human mesenchymal stem cells and biomaterials interaction: a promising synergy to improve spine fusion 87
null 87
A BETTER CLINICAL OUTCOME OF MERKEL CELL CARCINOMA PATIENTS IS ASSOCIATED WITH A HIGH LEVEL OF ANTIBODIES AGAINST MERKEL CELL POLYOMAVIRUS, A NEW SMALL DNA TUMOR VIRUS 86
B-LYMPHOCYTES FROM HEALTHY BLOOD DONORS TRANSFORMED BYSV40, A SMALL DNA TUMOR VIRUS 86
null 85
Biomaterials as bone graft substitutes for spine surgery: from preclinical results to clinical study. 82
Serum IgG antibodies from healthy subjects up to 100 years old react to JC polyomavirus 78
A FLUORESCENT OSTEOBLAST-LIKE CELL LINE FOR THE ASSAY OF BIOMATERIAL FEATURES 75
High Porosity Bioceramic is a Favourable Environment for the Adhesion and Proliferation of Human Mesenchymal Stem Cells. 71
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 71
MBL-2 GENE POLYMORPHISMS ASSOCIATED TO THE SUSCEPTIBILITY OF BKV INFECTION IN HPV-POSITIVE CERVICAL PRECANCEROUS LESIONS 71
SERA FROM PATIENTS AFFECTED BY MULTIPLE SCLEROSIS CONTAIN AT A HIGH PREVALENCE ANTIBODIES AGAINST BKV, A NEUROTROPIC POLYOMAVIRUS 68
Mesenchymal stem cell behavior in biomaterials assays 66
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 63
BIOMATERIALI ALTAMENTE POROSI GARANTISCONO UN AMBIENTE FAVOREVOLE ALLA CRESCITA DI CELLULE STAMINALI MESENCHIMALI 62
NEW GENERATION OF ORTHOPEDIC MIMETIC BIOCERAMICS ASSAYED WITH HUMAN MESENCHYMAL STEM CELLS 61
BUFFY COATS OF HEALTHY BLOOD DONORS CARRY SEQUENCES OF SMALL DNA TUMOR VIRUS NAMED MERKEL CELL POLYOMAVIRUS 59
Mother-to-child transmission of oncogenic polyomaviruses BKPyV, JCPyV and SV40 47
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 47
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 44
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 36
High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients With Critical Limb Ischemia and Foot Lesions 34
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 34
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 32
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 21
Human mesenchymal stem cells are regulated by specific microRNAs during the early stage of osteogenesis 20
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 20
The combination of chest computed tomography and standard electrocardiogram provides prognostic information and pathophysiological insights in COVID-19 pneumonia 19
Circulating Biomarkers of Endothelial Dysfunction and Inflammation in Predicting Clinical Outcomes in Diabetic Patients with Critical Limb Ischemia 18
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 18
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 18
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 18
Novel engineered human fluorescent osteoblasts for scaffolds bioassays 16
Osteoconductivity of Complex Biomaterials Assayed by Fluorescent-Engineered Osteoblast-like Cells 14
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 12
Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions 11
Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. 11
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 10
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 9
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 7
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 3
Pacemaker need after sutureless aortic valve replacement: The role of the learning curve 2
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 1
Minimally invasive aortic valve surgery in obese patients: Can the bigger afford the smaller? 1
Totale 3.970
Categoria #
all - tutte 17.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020763 116 28 29 94 47 103 73 79 77 57 37 23
2020/2021659 53 65 29 57 75 72 32 75 20 87 53 41
2021/2022362 18 39 12 16 22 18 17 18 19 33 32 118
2022/2023489 52 36 34 40 95 54 24 30 54 18 37 15
2023/2024416 25 42 19 15 36 92 22 31 8 11 10 105
2024/202530 30 0 0 0 0 0 0 0 0 0 0 0
Totale 3.970